{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825893676878720.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1093/sleep/32.2.181"}},{"identifier":{"@type":"URI","@value":"http://academic.oup.com/sleep/article-pdf/32/2/181/13664483/sleep-32-2-181.pdf"}},{"identifier":{"@type":"PMID","@value":"19238797"}}],"dc:title":[{"@value":"CSF Histamine Contents in Narcolepsy, Idiopathic Hypersomnia and Obstructive Sleep Apnea Syndrome"}],"description":[{"notation":[{"@value":"To (1) replicate our prior result of low cerebrospinal fluid (CSF) histamine levels in human narcolepsy in a different sample population and to (2) evaluate if histamine contents are altered in other types of hypersomnia with and without hypocretin deficiency.Cross sectional studies.Sixty-seven narcolepsy subjects, 26 idiopathic hypersomnia (IHS) subjects, 16 obstructive sleep apnea syndrome (OSAS) subjects, and 73 neurological controls were included. All patients were Japanese. Diagnoses were made according to ICSD-2.We found significant reductions in CSF histamine levels in hypocretin deficient narcolepsy with cataplexy (mean +/- SEM; 176.0 +/- 25.8 pg/mL), hypocretin non-deficient narcolepsy with cataplexy (97.8 +/- 38.4 pg/mL), hypocretin non-deficient narcolepsy without cataplexy (113.6 +/- 16.4 pg/mL), and idiopathic hypersomnia (161.0 +/- 29.3 pg/ mL); the levels in OSAS (259.3 +/- 46.6 pg/mL) did not statistically differ from those in the controls (333.8 +/- 22.0 pg/mL). Low CSF histamine levels were mostly observed in non-medicated patients; significant reductions in histamine levels were evident in non-medicated patients with hypocretin deficient narcolepsy with cataplexy (112.1 +/- 16.3 pg/ mL) and idiopathic hypersomnia (143.3 +/- 28.8 pg/mL), while the levels in the medicated patients were in the normal range.The study confirmed reduced CSF histamine levels in hypocretin-deficient narcolepsy with cataplexy. Similar degrees of reduction were also observed in hypocretin non-deficient narcolepsy and in idiopathic hypersomnia, while those in OSAS (non central nervous system hypersomnia) were not altered. The decrease in histamine in these subjects were more specifically observed in non-medicated subjects, suggesting CSF histamine is a biomarker reflecting the degree of hypersomnia of central origin."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420845751140532992","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"50323150"},{"@type":"NRID","@value":"1000050323150"},{"@type":"NRID","@value":"9000258058277"},{"@type":"NRID","@value":"9000257871548"},{"@type":"NRID","@value":"9000412092398"},{"@type":"NRID","@value":"9000343331275"},{"@type":"NRID","@value":"9000410322454"},{"@type":"NRID","@value":"9000406309809"},{"@type":"NRID","@value":"9000259838202"},{"@type":"NRID","@value":"9000398287388"},{"@type":"NRID","@value":"9000018728118"},{"@type":"NRID","@value":"9000409859217"},{"@type":"NRID","@value":"9000415315317"},{"@type":"NRID","@value":"9000370739671"},{"@type":"NRID","@value":"9000356635090"},{"@type":"NRID","@value":"9000241967051"},{"@type":"NRID","@value":"9000015174827"},{"@type":"NRID","@value":"9000361229843"},{"@type":"NRID","@value":"9000368922213"},{"@type":"NRID","@value":"9000022064527"},{"@type":"NRID","@value":"9000252120286"},{"@type":"NRID","@value":"9000411235398"},{"@type":"NRID","@value":"9000021260241"},{"@type":"NRID","@value":"9000382215196"},{"@type":"NRID","@value":"9000259838197"},{"@type":"NRID","@value":"9000413730450"},{"@type":"NRID","@value":"9000389959297"},{"@type":"NRID","@value":"9000345289404"},{"@type":"NRID","@value":"9000360553852"},{"@type":"NRID","@value":"9000399803164"},{"@type":"NRID","@value":"9000283542093"},{"@type":"NRID","@value":"9000258061259"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/tkanbayashi"}],"foaf:name":[{"@value":"Takashi Kanbayashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676878724","@type":"Researcher","foaf:name":[{"@value":"Tohru Kodama"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676878727","@type":"Researcher","foaf:name":[{"@value":"Hideaki Kondo"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676878725","@type":"Researcher","foaf:name":[{"@value":"Shinsuke Satoh"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676878720","@type":"Researcher","foaf:name":[{"@value":"Yuichi Inoue"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676878722","@type":"Researcher","foaf:name":[{"@value":"Shigeru Chiba"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676878726","@type":"Researcher","foaf:name":[{"@value":"Tetsuo Shimizu"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893676878723","@type":"Researcher","foaf:name":[{"@value":"Seiji Nishino"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01618105"},{"@type":"EISSN","@value":"15509109"}],"prism:publicationName":[{"@value":"Sleep"}],"dc:publisher":[{"@value":"Oxford University Press (OUP)"}],"prism:publicationDate":"2009-02","prism:volume":"32","prism:number":"2","prism:startingPage":"181","prism:endingPage":"187"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"http://academic.oup.com/sleep/article-pdf/32/2/181/13664483/sleep-32-2-181.pdf"}],"createdAt":"2017-04-20","modifiedAt":"2017-08-24","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Disorders%20of%20Excessive%20Somnolence","dc:title":"Disorders of Excessive Somnolence"},{"@id":"https://cir.nii.ac.jp/all?q=Young%20Adult","dc:title":"Young Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Cataplexy","dc:title":"Cataplexy"},{"@id":"https://cir.nii.ac.jp/all?q=Reference%20Values","dc:title":"Reference Values"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Narcolepsy","dc:title":"Narcolepsy"},{"@id":"https://cir.nii.ac.jp/all?q=Aged,%2080%20and%20over","dc:title":"Aged, 80 and over"},{"@id":"https://cir.nii.ac.jp/all?q=Orexins","dc:title":"Orexins"},{"@id":"https://cir.nii.ac.jp/all?q=Sleep%20Apnea,%20Obstructive","dc:title":"Sleep Apnea, Obstructive"},{"@id":"https://cir.nii.ac.jp/all?q=Neuropeptides","dc:title":"Neuropeptides"},{"@id":"https://cir.nii.ac.jp/all?q=Intracellular%20Signaling%20Peptides%20and%20Proteins","dc:title":"Intracellular Signaling Peptides and Proteins"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Antidepressive%20Agents","dc:title":"Antidepressive Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Cross-Sectional%20Studies","dc:title":"Cross-Sectional Studies"},{"@id":"https://cir.nii.ac.jp/all?q=Central%20Nervous%20System%20Stimulants","dc:title":"Central Nervous System Stimulants"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Nervous%20System%20Diseases","dc:title":"Nervous System Diseases"},{"@id":"https://cir.nii.ac.jp/all?q=Histamine","dc:title":"Histamine"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360005519193306752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cerebrospinal fluid neurotransmitter levels and central nervous system depression in a rat drug overdose model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643718584832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Metabolome analysis using cerebrospinal fluid from narcolepsy type 1 patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189449184512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Histamine N-Methyltransferase in the Brain"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660723549952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High‐amplitude theta wave bursts characterizing narcoleptic mice and patients are also produced by histamine deficiency in mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567461375616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567794500352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Organic Cation Transporters in Brain Histamine Clearance: Physiological and Psychiatric Implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1390588910413570816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"ヒスタミン代謝酵素阻害薬による新規過眠症治療戦略"},{"@language":"en","@value":"Therapeutic potential of histamine <i>N</i>-methyltransferase inhibition for the treatment of hypersomnia"},{"@language":"ja-Kana","@value":"ヒスタミン タイシャ コウソ ソガイヤク ニ ヨル シンキ カミンショウ チリョウ センリャク"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/sleep/32.2.181"},{"@type":"OPENAIRE","@value":"doi_dedup___::a6e42776f7be5ae3ee8c16e3fd95261c"},{"@type":"CROSSREF","@value":"10.1080/15376516.2019.1672122_references_DOI_LPZ3bpS1hwGjZlk4kfKG11JghjJ"},{"@type":"CROSSREF","@value":"10.1093/sleep/zsaa095_references_DOI_LPZ3bpS1hwGjZlk4kfKG11JghjJ"},{"@type":"CROSSREF","@value":"10.3390/ijms20030737_references_DOI_LPZ3bpS1hwGjZlk4kfKG11JghjJ"},{"@type":"CROSSREF","@value":"10.1111/jsr.12404_references_DOI_LPZ3bpS1hwGjZlk4kfKG11JghjJ"},{"@type":"CROSSREF","@value":"10.1111/bph.15220_references_DOI_LPZ3bpS1hwGjZlk4kfKG11JghjJ"},{"@type":"CROSSREF","@value":"10.1007/164_2021_447_references_DOI_LPZ3bpS1hwGjZlk4kfKG11JghjJ"},{"@type":"CROSSREF","@value":"10.1254/fpj.25070_references_DOI_LPZ3bpS1hwGjZlk4kfKG11JghjJ"}]}